|
English
|
正體中文
|
简体中文
|
0
|
|
???header.visitor??? :
52265544
???header.onlineuser??? :
875
???header.sponsordeclaration???
|
|
|
|
???tair.name??? >
???browser.page.title.author???
|
"fu s h"???jsp.browse.items-by-author.description???
Showing items 11-20 of 68 (7 Page(s) Totally)
<< < 1 2 3 4 5 6 7 > >>
View [10|25|50] records per page
| 臺大學術典藏 |
2022-09-19T03:16:46Z |
Use of dipeptidyl peptidase-4 inhibitors and the risk of arthralgia: Population-based cohort and nested case–control studies
|
Wang C.-Y.; Fu S.-H.; Yang R.-S.; FEI-YUAN HSIAO |
| 臺大學術典藏 |
2022-09-19T03:16:38Z |
Timing of anti-osteoporosis medications initiation after a hip fracture affects the risk of subsequent fracture: A nationwide cohort study
|
Wang C.-Y.; Fu S.-H.; Yang R.-S.; Chen L.-K.; Shen L.-J.; FEI-YUAN HSIAO |
| 臺大學術典藏 |
2022-09-19T03:16:30Z |
Increased fracture risk after discontinuation of anti-osteoporosis medications among hip fracture patients: A population-based cohort study
|
Fu S.-H.; Wang C.-Y.; Hung C.-C.; Lee C.-C.; Yang R.-S.; Huang C.-C.; Farn C.-J.; Lin W.-H.; Chen H.-M.; FEI-YUAN HSIAO; Lin J.-W.; Li C.-Y. |
| 臺大學術典藏 |
2022-09-19T03:16:26Z |
Impact of the Requirement of Bone Mineral Density Evidence on Utilization of Anti-osteoporosis Medications, Clinical Outcome and Medical Expenditures of Patient With Hip Fracture in Taiwan
|
Wang C.-Y.; Fu S.-H.; Hung C.-C.; Yang R.-S.; Lin J.-W.; Chen H.-M.; FEI-YUAN HSIAO; Shen L.-J. |
| 臺大學術典藏 |
2022-09-06T08:38:44Z |
Impact of the Requirement of Bone Mineral Density Evidence on Utilization of Anti-osteoporosis Medications, Clinical Outcome and Medical Expenditures of Patient With Hip Fracture in Taiwan
|
Wang C.-Y.; Fu S.-H.; Hung C.-C.; Yang R.-S.; Lin J.-W.; Chen H.-M.; Hsiao F.-Y.; LI-JIUAN SHEN |
| 臺大學術典藏 |
2022-05-24T06:14:05Z |
Accelerometer-Based Body Sensor Network (BSN) for Medical Diagnosis Assessment and Training
|
Lee M.;Lei K.F.;Lin W.;Shieh W.;Tsai W.;Fu S.H.;Kuo C.; Lee M.; Lei K.F.; Lin W.; Shieh W.; Tsai W.; Fu S.H.; Kuo C.; CHUNG-HSIEN KUO |
| 臺大學術典藏 |
2022-01-12T08:06:08Z |
Increased fracture risk after discontinuation of anti-osteoporosis medications among hip fracture patients: A population-based cohort study
|
Fu S.-H.; Wang C.-Y.; Hung C.-C.; CHIA-CHE LEE; Yang R.-S.; Huang C.-C.; Farn C.-J.; Lin W.-H.; Chen H.-M.; Hsiao F.-Y.; Lin J.-W.; Li C.-Y. |
| 臺大學術典藏 |
2022-01-12T08:06:08Z |
A Multi-Institutional Randomized Controlled Trial to Investigate Whether Zoledronate Prevents Bone Loss After Discontinuation of Denosumab: The Study Protocol of Denosumab Sequential Therapy (DST) Trial
|
CHIA-CHE LEE; Wang C.-Y.; Hung C.-C.; Huang C.-C.; Li C.-Y.; Chen H.-Y.; Chang Y.-L.; Tseng W.-J.; Wang T.-M.; Yang R.-S.; Wong T.-H.; Fu S.-H. |
| 國立成功大學 |
2022 |
Authors' reply: Increased fracture risk after discontinuation of anti-osteoporosis medications among hip fracture patients
|
Fu, S.-H.;Wang, C.-Y.;Li, C.-Y. |
| 國立成功大學 |
2022 |
Improving the care stress, life quality, and family functions for family-caregiver in long-term care by home modification
|
Yang, S.-Y.;Fu, S.-H.;Hsieh, P.-L.;Lin, Y.-L.;Chen, M.-C.;Lin, P.-H. |
Showing items 11-20 of 68 (7 Page(s) Totally)
<< < 1 2 3 4 5 6 7 > >>
View [10|25|50] records per page
|
